Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0570
0.00 (0.00%)
At close: Feb 6, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $662.36 thousand as of February 9, 2026. Its market cap has decreased by -70.42% in one year.
Market Cap
662.36K
Enterprise Value
250.72K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 662.36K, a decrease of -95.22%. That is a compound annual growth rate of -22.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 662.36K | -5.00% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EV Biologics | 927.19K |
| Lipella Pharmaceuticals | 881.43K |
| Eastgate Biotech | 846.29K |
| Aibotics | 819.95K |
| Protagenic Therapeutics | 771.16K |
| SQZ Biotechnologies Company | 707.79K |
| Avenue Therapeutics | 631.21K |
| Helix BioMedix | 606.71K |